GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (STU:RTA1) » Definitions » YoY EBITDA Growth

Rite Aid (STU:RTA1) YoY EBITDA Growth : -304.93% (As of Aug. 2023)


View and export this data going back to 1970. Start your Free Trial

What is Rite Aid YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Rite Aid's YoY EBITDA Growth for the quarter that ended in Aug. 2023 was -304.93%.

Rite Aid's EBITDA per Share for the three months ended in Aug. 2023 was €-14.53.


Rite Aid YoY EBITDA Growth Historical Data

The historical data trend for Rite Aid's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid YoY EBITDA Growth Chart

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.76 12,921.88 -23.31 -114.24 -386.94

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -994.51 -21.47 51.69 -1,551.50 -304.93

Rite Aid YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Rite Aid's YoY EBITDA Growth for the fiscal year that ended in Feb. 2023 is calculated as:

YoY EBITDA Growth (A: Feb. 2023 )
=(EBITDA per Share (A: Feb. 2023 )-EBITDA per Share (A: Feb. 2022 ))/ | EBITDA per Share (A: Feb. 2022 ) |
=(-4.363--0.896)/ | -0.896 |
=-386.94 %

Rite Aid's YoY EBITDA Growth for the quarter that ended in Aug. 2023 is calculated as:

YoY EBITDA Growth (Q: Aug. 2023 )
=(EBITDA per Share (Q: Aug. 2023 )-EBITDA per Share (Q: Aug. 2022 )) / | EBITDA per Share (Q: Aug. 2022 )) |
=(-14.525--3.587)/ | -3.587 |
=-304.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rite Aid YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Rite Aid's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (STU:RTA1) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.

Rite Aid (STU:RTA1) Headlines

No Headlines